Reported about 23 hours ago
McKinsey & Co has settled a U.S. Department of Justice investigation by agreeing to pay $650 million due to its role in advising Purdue Pharma, the maker of OxyContin, on increasing opioid sales, contributing to the opioid epidemic. The firm entered a five-year deferred prosecution agreement and faced charges including conspiracy and obstruction of justice, with a former partner also pleading guilty to related charges. This settlement is part of a series of legal actions where McKinsey has resolved nearly $1 billion in claims across various sectors regarding its involvement in the opioid crisis.
Source: YAHOO